Sleep Medicine

The Psychosocial Impact of COVID-19 in Neurology Departments

September 10, 2020

Leah Croll, MD, a neurology resident on the front lines of the COVID-19 pandemic, shares details from her study on the psychosocial impact on physicians and her first-hand experience.

Lacosamide Meets Primary End Point, Lemborexant Well-Tolerated in Elders, Cala Trio Reduces Hand Tremor

September 05, 2020

Neurology News Network for the week ending September 5, 2020.

Pitolisant Shows No Cardiac Safety Signals in Narcolepsy

September 04, 2020

Despite previous literature documenting cardiovascular disease comorbidity in patients with narcolepsy, pitolisant treatment did not demonstrate any cardiac safety signals.

Longitudinal Sleep Problems in Children Linked With Negative Well-Being

September 02, 2020

The findings support the integration of sleep assessments into routine developmental screenings in school and primary care settings.

Solriamfetol Improves Excessive Daytime Sleepiness and Driving Performance Ability

September 01, 2020

The FDA-approved agent showed significant impact in decreasing standard deviation of lateral position, a measure used to assess driving performance.